Ali Canbay

21.0k citations
375 papers · 14.8k · 8 hit papers · h-index 57

Impact in

  • Hepatology top 0.1%
    • Liver Disease and Transplantation
    • Liver physiology and pathology
  • Epidemiology top 0.05%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Liver Disease Diagnosis and Treatment 142
    • Hepatitis B Virus Studies 21
    • Liver Disease and Transplantation 65
    • Liver Diseases and Immunity 20
    • Liver physiology and pathology 19

Ali Canbay

347 papers receiving 14.5k citations

Ali Canbay's Hit Papers

Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells 2024 · 63 citations
630+7+15Years since publication250500750

Peers

Ali Canbay
Comparison fields: 5 of 161
  • Hepatology 4.0k
  • Epidemiology 7.4k
  • Endocrinology, Diabetes and Metabolism 1.7k
  • Pharmacology 962
  • Cell Biology 1.2k
Replace Fabio Marra with:
Fabio Marra Italy
Isabelle Leclercq Belgium
Matthew M. Yeh United States
Jacob George Australia
Shuichi Kaneko Japan
Alastair D. Burt United Kingdom
Manuel Romero‐Gómez Spain
Massimo Pinzani Italy
Oscar W. Cummings United States
Koichi Tsuneyama Japan
Ali Canbay relative to Fabio Marra Italy Fabio Marra's profile →
Citations per field
00.5×1.5×
Fabio Marra · 1×
Citations per year

Countries citing papers authored by Ali Canbay

Since Specialization
Citations

This map shows the geographic impact of Ali Canbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Canbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Canbay more than expected).

Fields of papers citing papers by Ali Canbay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Canbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Canbay. The network helps show where Ali Canbay may publish in the future.

Co-authors

The 25 scholars most cited alongside Ali Canbay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ali Canbay Line = papers co-authored together Ali Canbay links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 375 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Hit paper breakdown →
2003862
2
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
Hit paper breakdown →
2013795
3
The interaction of hepatic lipid and glucose metabolism in liver diseases
Hit paper breakdown →
2011773
4
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
Hit paper breakdown →
2004655
5
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
Hit paper breakdown →
2013497
6
Extrahepatic complications of nonalcoholic fatty liver disease
Hit paper breakdown →
2013461
7 2004423
8
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Hit paper breakdown →
2014409
9 2010384
10 2003368
11 2003326
12 2003264
13 2014243
14 2002233
15 2013189
16 2004173
17 2010172
18 2002171
19 2003165
20 2003162

About Ali Canbay

Ali Canbay is a scholar working on Epidemiology, Hepatology, Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 375 papers that have together received 14.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (142 papers), Liver Disease and Transplantation (65 papers), Diet, Metabolism, and Disease (31 papers), Drug-Induced Hepatotoxicity and Protection (27 papers), Organ Transplantation Techniques and Outcomes (22 papers), Hepatitis B Virus Studies (21 papers), Liver Diseases and Immunity (20 papers) and Liver physiology and pathology (19 papers). The work is most often cited by research in Hepatology (4.0k citations), Epidemiology (7.4k citations), Endocrinology, Diabetes and Metabolism (1.7k citations), Pharmacology (962 citations) and Cell Biology (1.2k citations). Ali Canbay has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Gregory J. Gores, Guido Gerken, Ariel E. Feldstein, Lars P. Bechmann, Alexander Wree, Jan‐Peter Sowa, Steven F. Bronk, Hajime Higuchi, Hal M. Hoffman and Wing‐Kin Syn. Their work appears in journals such as Digestion, Journal of Hepatology, Liver International, Hepatology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact